Definium Therapeutics, Inc. Common Shares (DFTX) is a publicly traded the market company. As of July 14, 2026, DFTX trades at $43.77 with a market cap of $6.25B and a P/E ratio of 0.00. DFTX moved +0.26% today. Year to date, DFTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $14.62 to $49.20. Analyst consensus is strong buy with an average price target of $56.83. Rallies surfaces DFTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Definium Therapeutics, Inc. Common Shares (DFTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DFTX moved +0.26% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $43.77 |
| Market Cap | $6.25B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.20 |
| 52-Week Low | $14.62 |
| Volume | 527 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
12 analysts cover DFTX: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.83.